Literature DB >> 8904403

Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria.

S K Schmitt1, C Knapp, G S Hall, D L Longworth, J T McMahon, J A Washington.   

Abstract

To assess the impact of the antiseptic effects of silver sulfadiazine-chlorhexidine-impregnated central venous catheters on catheter culture systems, a series of in vitro experiments was performed. Segments of antiseptic and non-antiseptic-impregnated catheters were sonicated in thioglycolate broth and removed. After the addition of 10(3) CFU of Staphylococcus epidermidis per ml, aliquots of catheter-exposed broth were subcultured onto blood agar at 15-min intervals. Decreased mean colony counts were noted at 45 min for broth exposed to antiseptic-impregnated catheters compared with the colony counts for broth exposed to non-antiseptic-impregnated catheters (170 versus 540 CFU/ml). These effects, which were also demonstrated by the roll-plate method, were abrogated by the use of medium containing inhibitors of silver sulfadiazine and chlorhexidine. To assess the duration of the antiseptic effects, catheter segments were suspended for up to 14 days in phosphate-buffered saline, incubated with 10(6) CFU of S. epidermidis per ml, and cultured. Inhibition of bacterial growth by antiseptic-impregnated catheters disappeared after 14 days. These studies suggest that antiseptic compounds elute from catheters during broth- and solid medium-based culturing processes, making necessary the addition of inhibitors of these compounds in culture media. They further suggest that the antimicrobial effects of antiseptic-impregnated catheters wane within several days of placement.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904403      PMCID: PMC228835          DOI: 10.1128/jcm.34.3.508-511.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory.

Authors:  R J Sherertz; I I Raad; A Belani; L C Koo; K H Rand; D L Pickett; S A Straub; L L Fauerbach
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

2.  Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.

Authors:  D G Maki; M Ringer; C J Alvarado
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

3.  Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.

Authors:  D G Maki; J T Botticelli; M L LeRoy; T S Thielke
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

4.  A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors:  D G Maki; C E Weise; H W Sarafin
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

5.  Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.

Authors:  I I Raad; D C Hohn; B J Gilbreath; N Suleiman; L A Hill; P A Bruso; K Marts; P F Mansfield; G P Bodey
Journal:  Infect Control Hosp Epidemiol       Date:  1994-04       Impact factor: 3.254

6.  A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters.

Authors:  D K Cobb; K P High; R G Sawyer; C A Sable; R B Adams; D A Lindley; T L Pruett; K J Schwenzer; B M Farr
Journal:  N Engl J Med       Date:  1992-10-08       Impact factor: 91.245

7.  Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System.

Authors:  W R Jarvis; J R Edwards; D H Culver; J M Hughes; T Horan; T G Emori; S Banerjee; J Tolson; T Henderson; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

  7 in total
  8 in total

1.  The relationship between methodological trial quality and the effects of impregnated central venous catheters.

Authors:  Christine Geffers; Irina Zuschneid; Tim Eckmanns; Henning Rüden; Petra Gastmeier
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

2.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

3.  A comparative assessment of two conservative methods for the diagnosis of catheter-related infection in critically ill patients.

Authors:  John R Gowardman; Paula Jeffries; Melissa Lassig-Smith; Janine Stuart; Paul Jarrett; Renae Deans; Matthew McGrail; Narelle M George; Graeme R Nimmo; Claire M Rickard
Journal:  Intensive Care Med       Date:  2012-09-26       Impact factor: 17.440

4.  Microbicidal activity of a new silver-containing polymer, SPI-ARGENT II.

Authors:  G Kampf; B Dietze; C Grosse-Siestrup; C Wendt; H Martiny
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria.

Authors:  A Bach
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

6.  Antiseptic-impregnated central venous catheters: their evaluation in burn patients.

Authors:  G Ramos; A Bolgiani; O Patiño; G Prezzavento; P Guastavino; R Durlach; L Fernandez Caniggia; F Benaim
Journal:  Ann Burns Fire Disasters       Date:  2006-06-30

7.  Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.

Authors:  M N Carrasco; A Bueno; C de las Cuevas; S Jimenez; I Salinas; A Sartorius; T Recio; M Generelo; F Ruiz-Ocaña
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

Review 8.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.